<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Recent studies have demonstrated that neurotrophic factors promote neurogenesis after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, it remains unknown whether administration of genes encoding those factors could promote neural regeneration in the striatum and functional recovery </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we examined the efficacy of intraventricular injection of a recombinant adenovirus-expressing <z:chebi fb="5" ids="28304">heparin</z:chebi>-binding epidermal growth factor-like growth factor (HB-EGF) on neurogenesis, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and functional outcome after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Transient focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 80 minutes with a nylon filament in Wistar rats </plain></SENT>
<SENT sid="4" pm="."><plain>Three days after MCAO, either adenovirus-expressing HB-EGF (Ad-HB-EGF) or Ad-LacZ, the control vector, was injected into the lateral ventricle on the ischemic side </plain></SENT>
<SENT sid="5" pm="."><plain>Bromodeoxyuridine (BrdU) was injected intraperitoneally twice daily on the sixth and seventh days </plain></SENT>
<SENT sid="6" pm="."><plain>On the eighth or 28th day after MCAO, we evaluated <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neurogenesis, and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> histologically </plain></SENT>
<SENT sid="7" pm="."><plain>Neurological outcome was serially evaluated by the rotarod test after MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS: There was no significant difference in <z:mpath ids='MPATH_124'>infarct</z:mpath> volume between the 2 groups </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment with Ad-HB-EGF significantly increased the number of BrdU-positive cells in the subventricular zone on the 8th day </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, on the 28th day, BrdU-positive cells differentiated into mature neurons in the striatum on the ischemic side but seldom the cells given Ad-LacZ </plain></SENT>
<SENT sid="11" pm="."><plain>Enhancement of <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> at the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> striatum was also observed on the eighth day in Ad-HB-EGF-treated rats </plain></SENT>
<SENT sid="12" pm="."><plain>Treatment with Ad-HB-EGF significantly enhanced functional recovery after MCAO </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSIONS: Our data suggest that gene therapy using Ad-HB-EGF contributes to functional recovery after <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> by promoting neurogenesis and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
</text></document>